$3.03 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRcall | $1,485,560,000 | – | 7,286,800 | +100.0% | 49.10% | – |
WMGI | New | WRIGHT MED GROUP N V | $64,638,000 | – | 2,673,193 | +100.0% | 2.14% | – |
KSU | New | KANSAS CITY SOUTHERN | $49,447,000 | – | 662,207 | +100.0% | 1.63% | – |
SHPG | New | SHIRE PLCsponsored adr | $28,882,000 | – | 140,886 | +100.0% | 0.96% | – |
PACB | New | PACIFIC BIOSCIENCES CALIF IN | $28,345,000 | – | 2,158,787 | +100.0% | 0.94% | – |
NKTR | New | NEKTAR THERAPEUTICS | $26,351,000 | – | 1,563,862 | +100.0% | 0.87% | – |
DXCM | New | DEXCOM INC | $22,853,000 | – | 279,040 | +100.0% | 0.76% | – |
TV | New | GRUPO TELEVISA SAspon adr rep ord | $17,655,000 | – | 648,825 | +100.0% | 0.58% | – |
WW | New | WEIGHT WATCHERS INTL INC NEWput | $6,840,000 | – | 300,000 | +100.0% | 0.23% | – |
ADPTQ | New | ADEPTUS HEALTH INCcl a | $6,789,000 | – | 124,529 | +100.0% | 0.22% | – |
CGIX | New | CANCER GENETICS INC | $173,000 | – | 52,508 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.